WASHINGTON, DC — Measures of liver stiffness remained stable or improved in patients with primary biliary cholangitis (PBC) after 36 months of treatment with seladelpar (Livdelzi) based on new data ...

PSC Affects Outcomes in Paediatric IBD Patients with paediatric-onset IBD and concomitant primary sclerosing cholangitis have substantially worse outcomes, with elevated risks for cancer and death.

Nagoya University researchers and their collaborators have found that minimally invasive laparoscopic surgery significantly reduces blood loss and improves jaundice recovery compared to traditional ...

Pediatric liver disease is a rare but potentially life-threatening condition that differs significantly from adult liver disease in terms of causes and progression. Unlike adults, where cirrhosis and ...

Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow Disease Progression – New Data ...